Telix Pharma (TLX) is held by 32 ASX ETFs. Over the last month it fell 3.9%: on $10,000, −$394. We explain 2 big moves in that time.
About TLX
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$5.4b
- Held by32 ETFs
- Big moves2 in 1M
Last month−3.9%
$15.85−3.94% price
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
1M high$17.85
1M low$15.16
Avg volume2.5m
Latest volume1.0m
Prices to 9 Oct closeNo distributions in this period
Why it moved
2 moves
- −10.3%21 Sep 2026· Takeover / M&A
Telix Pharmaceuticals shares fell sharply after announcing a major US$1.65 billion acquisition of ITM Isotope Technologies, with investors reacting negatively to the scale and cost of the deal.
- +11.2%15 Sep 2026· Sector Flow
The ASX Health Care sector rose strongly on the same day, lifting TLX as part of a broad sector rotation into health stocks.
Held by 32 ETFs
Of every $10,000 in each fund, how much is in TLX today.
- MVEVanEck S&P/ASX MidCap ETF$1471.47%
- FAIRBetaShares Australian Sustainability Leaders ETF$920.92%
- VSOVanguard MSCI Australian Small Companies Index ETF$760.76%
- GRNVVanEck MSCI Australian Sustainable Equity ETF$620.62%
- OZXXGlobal X Australia ex Financials & Resources ETF$560.56%
- EX20BetaShares Australian Ex-20 Portfolio Diversifier ETF$470.47%
- GEARBetaShares Geared Australian Equities Complex ETF$380.38%
- VETHVanguard Ethically Conscious Australian Shares ETF$230.23%
- AYLDGlobal X S&P/ASX 200 Covered Call Complex ETF$180.18%
- STWSTATE STREET SPDR S&P/ASX 200 ETF$180.18%